(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-18 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 8270
| Date | Daily Closing Price | Open | High | Low | Volume |
| 18 Wed Sep 2024 | 2.41 | 2.41 | 2.41 | 2.40 | 0.218 times |
| 17 Tue Sep 2024 | 2.45 | 2.49 | 2.49 | 2.30 | 1.318 times |
| 16 Mon Sep 2024 | 2.54 | 2.48 | 2.54 | 2.47 | 0.726 times |
| 13 Fri Sep 2024 | 2.63 | 2.47 | 2.63 | 2.47 | 0.242 times |
| 12 Thu Sep 2024 | 2.64 | 2.62 | 2.64 | 2.50 | 0.544 times |
| 11 Wed Sep 2024 | 2.66 | 2.62 | 2.66 | 2.55 | 0.641 times |
| 10 Tue Sep 2024 | 2.64 | 2.65 | 2.65 | 2.60 | 0.109 times |
| 09 Mon Sep 2024 | 2.67 | 2.70 | 2.70 | 2.55 | 1.536 times |
| 06 Fri Sep 2024 | 2.70 | 2.66 | 2.70 | 2.59 | 1.088 times |
| 05 Thu Sep 2024 | 2.70 | 2.56 | 2.73 | 2.56 | 0.52 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 2.4, for a target of 2.6 or 2.65
Share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Target | 1.85 |
| Downside Target | 2.10 |
| Downside Target | 2.16 |
| Downside Target | 2.30 |
| Downside Target | 2.39 |
| Upside Target | 2.47 |
| Upside Target | 2.52 |
| Upside Target | 2.70 |
| Upside Target | 2.79 |
| Upside Target | 2.81 |
| Upside Target | 2.97 |
| Upside Target | 3.05 |
| Upside Target | 3.15 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Intraday Target | 2.29 |
| Downside Intraday Target | 2.18 |
| Upside Intraday Target | 2.53 |
| Upside Intraday Target | 2.66 |
| Upside Intraday Target | 2.42 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 18 Wed Sep 2024 | 2.41 | 2.48 | 2.54 | 2.30 | 0.736 times |
| 13 Fri Sep 2024 | 2.63 | 2.70 | 2.70 | 2.47 | 0.508 times |
| 06 Fri Sep 2024 | 2.70 | 2.79 | 2.79 | 2.56 | 71.429 times |
| 30 Fri Aug 2024 | 2.79 | 2.65 | 2.79 | 2.54 | 0.017 times |
| 30 Fri Aug 2024 | 2.79 | 2.71 | 2.79 | 2.52 | 0.623 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 18 Wed Sep 2024 | 2.41 | 2.79 | 2.79 | 2.30 | 0.5 times |
| 30 Fri Aug 2024 | 2.79 | 2.85 | 2.97 | 2.39 | 0.503 times |
| 31 Wed Jul 2024 | 2.88 | 2.39 | 3.05 | 2.16 | 0.656 times |
| 28 Fri Jun 2024 | 2.43 | 2.57 | 2.81 | 1.85 | 2.184 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.61 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.61 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.